SCHEMBL3547077

SCHEMBL3547077

CCc1c(C=O)cc(C)n1-c1cc(F)cc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 16/20 0.44
MAPT P10636 2/20 0.44
POLB P06746 3/20 0.41
CTDSP1 Q9GZU7 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
CASP6 P55212 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
APEX1 P27695 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
NSD2 O96028 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3541967 0.85 ALDH1A1 (0.41) ALDH1A1MAPTPOLBCTDSP1L3MBTL1
SCHEMBL3538122 0.74 OPRL1 (0.33) POLB
SCHEMBL3545131 0.72 MAPK1 (0.48) ALDH1A1MAPTL3MBTL1KDM4EHTT
SCHEMBL21225466 0.67 ALDH1A1 (0.61) ALDH1A1MAPTPOLBCTDSP1L3MBTL1
SCHEMBL14905703 0.66 POLB (0.40) ALDH1A1POLBKDM4EHTTLMNA
SCHEMBL13264146 0.65 ERN1 (0.42) ALDH1A1MAPTL3MBTL1KDM4ELMNA
SCHEMBL3045790 0.64 NR4A1 (0.47) ALDH1A1MAPTPOLBL3MBTL1KDM4E
SCHEMBL10226082 0.62 ERN1 (0.44) ALDH1A1MAPTL3MBTL1KDM4ELMNA
SCHEMBL716443 0.62 POLB (0.42) ALDH1A1MAPTPOLBKDM4ELMNA
SCHEMBL24105759 0.61 ERN1 (0.52) ALDH1A1MAPTPOLBL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US disclosed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US disclosed
EP-1935881-A1 ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds OPRL1, NPSR1, NPBWR1 ALDH1A1 1623/4885MAPT 2946/4885POLB 4463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.